Riskpilot← Back to searchSign inGet full accessBIONOR HOLDING AS
ASActiveOrg 919282134Gaustadalléen 21, 0349 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20170 employees
Revenue 2024
NOK 0
EBITDA margin
—
+89% vs 2023
Equity ratio
-2050.9%
Financial strength
Net profit 2024
NOK -149K
+79% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -81K | +89% |
| Net profit | NOK -149K | +79% |
| Total assets | NOK 40K | -9% |
| Equity | NOK -819K | -22% |
| Employees | 0 | — |
Legal name
BIONOR HOLDING AS
Org number
919282134
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. juli 2017
Share capital
NOK 45 582
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder.
Company purpose
Å utvikle, kjøpe og eie selskap med vaksiner for kommersialisering herunder videreutvikle alene eller med partner (e) for ut-lisensiering og salg samt annet som naturlig faller sammen med dette.
Address
Gaustadalléen 21, 0349 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −2 834 | −3 022 | −3 746 | −722 | −81 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 834 | −3 022 | −3 746 | −722 | −81 |
| Net financials | 0 | −0 | 0 | 0 | −68 |
| Profit before tax | −2 834 | −3 023 | −3 746 | −722 | −149 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 834 | −3 023 | −3 746 | −722 | −149 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 123 | 112 | 468 | 44 | 40 |
| Equity | 3 103 | 80 | 51 | −671 | −819 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 21 | 32 | 417 | 714 | 859 |
| Total debt | 21 | 32 | 417 | 714 | 859 |
EBITDA margin
-8057600.0%
This company
15.8%
Market median
-50997568% vs market
20202024
Equity ratio
-2050.9%
This company
38.2%
Market median
-5469% vs market
20202024
Return on equity
-14889600.0%
This company
18.4%
Market median
-80921839% vs market
20202024
Net profit margin
-14889600.0%
This company
8.1%
Market median
-183822322% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AA Contact Person | Contact Person | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
| Former (2) | ||
| Board of Directors | 2017 – 2024 | |
| Board of Directors | 2017 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 35.87% | 35.87% | 2024 | |
Wivel Invest As | Company | 12% | 12% | 2024 |
| Company | 10.02% | 10.02% | 2024 | |
| Company | 7.48% | 7.48% | 2024 | |
Svenska Handelsbanken Ab | Company | 6.83% | 6.83% | 2024 |
| Company | 6.63% | 6.63% | 2024 | |
| Individual | 5.22% | 5.22% | 2022 | |
| Company | 3.44% | 3.44% | 2024 | |
| Company | 2.8% | 2.8% | 2024 | |
| Company | 2.24% | 2.24% | 2024 | |
| Company | 1.7% | 1.7% | 2024 | |
| Company | 1.7% | 1.7% | 2024 | |
| Company | 1.5% | 1.5% | 2024 | |
| Company | 1.1% | 1.1% | 2024 | |
| Individual | 1.1% | 1.1% | 2023 | |
| Individual | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIONOR HOLDING AS 
BIONOR IMMUNO ASBoard members of BIONOR HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aslak Aslaksen | Contact Person | 0 companies |
| Dag Arne Wivelstad | Board of Directors | 0 companies |
| Birger Sørensen | Chairman | 0 companies |
| Knut Terje Smerud | Board of Directors | 0 companies |